The Platform Trial in COVID-19 Priming and BOOsting (PICOBOO): the Immunogenicity, Reactogenicity, and Safety of Different COVID-19 Vaccinations Administered As a Second Booster (fourth Dose) in AZD1222 Primed Individuals Aged 50-<70 Years Old.
Journal of Infection(2024)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要